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H. Zhao, J.^^F. Hartwig and coworkers combined successfully homogeneous alkene 
metathesis and biocatalysis in a concurrent fashion. A Ru-NHC complex provides an 
equilibrating mixture of cross metathesis products. The selective simultaneous epoxidation by 
P450 BM3 enables product yields well above the hypothetical two-step process. 
Enzymatic and chemocatalysis have developed widely independently to address 
synthetic challenges in the production of fine chemicals. The parallel development can partly 
be attributed to the historical division of the scientific communities from which they originate 
- micro- and molecular biologists on the enzymatic side, whereas organic/inorganic chemists 
were concerned with the development of chemocatalysis. 
Both approaches provide now a wealth of methods to create added value, but can be 
considered complementary in many aspects, not least the range of reactions they catalyse. 
Chemocatalysts have traditionally been optimized mostly for use in organic solvents. 
They typically accept a large substrate scope for a given transformation, but often require 
stringent conditions, including the exclusion of water and oxygen. 
Biocatalysts in contrast, operate in complex media such as cell lysates, provide 
frequently excellent selectivity but often display limited substrate scope, which may be traced 
back to their exquisite performance. 
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Combining chemo- and enzymatic catalysis in a concurrent fashion is considered 
challenging due to compatibility issues of the catalysts and/or the reaction conditions of the 
individual steps. Despite this, their combination offers opportunities to outperform sequential 
transformations.[1] 
A successful concept where the concurrent application of chemo- and enzymatic 
catalysis can be exploited to particular advantage is the maintenance of an equilibrium of 
intermediates by means of a chemocatalyst and highly selective conversion of one of the 
intermediates by means of an enzymatic transformation (Scheme^^1). This was firmly 
established for a wide range of dynamic kinetic resolution reactions: a secondary alcohol or 
an α-branched amine is racemized by a transition metal catalyst and only one of the 
enantiomers is converted concurrently in a lipase-mediated acylation reaction.[2] 
Zhao, Hartwig and coworkers have elegantly expanded this concept of dynamic 
catalyst cooperation in a proof of principle study by combining alkene metathesis, a bio-
complementary reaction par excellence, with a P450-mediated alkene epoxidation.[3] 
Alkene metathesis ranks amongst the most prominent organometallic catalytic 
reactions of the last two decades. Its popularity was boosted by the introduction of easy to 
handle homogeneous ruthenium and molybdenum catalysts. Although double bond geometry 
can now be controlled to a substantial extent in many inter- and intramolecular reactions in 
favor of the Z-isomer, cross metathesis of olefins can suffer additionally from the preferential 
formation of self-metathesis products.[4,^5] 
P450 monooxygenases have found widespread attention as potentially versatile 
biocatalysts, which enable oxidation of organic substrates under mild conditions using 
molecular oxygen and NAD(P)H. The soluble P450 BM3 from Bacillus megaterium is 
particularly attractive for synthetic applications as the reductase domain is fused with the 
oxidative heme center in a single polypeptide chain. The enzyme has a preference for fatty 
acids while the catalytic efficiency depends on substrate chain length. It can give rise to both 
epoxidation and hydroxylation and its specificity can be substantially tuned by genetic 
manipulation.[6] 
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The compatibility of the transition metal-based metathesis and the enzymatic oxidation 
catalyst was evaluated by comparing activities of the individual players in the presence of 
their idling catalytic partner. For the evaluation of the monooxygenase, a saturated carboxylic 
acid was hydroxylated. Likewise, a suitable metathesis catalyst compatible with P450 BM3 
was identified in the presence of NADP+ instead of the NADPH required for the oxidation 
step. Both catalysts tolerated each other under the biphasic reaction conditions 
(aqueous/isooctane) that were selected for cooperative catalysis. 
In the concurrent process, NADPH was regenerated by means of an engineered 
phosphite dehydrogenase (PTDH) from Pseudomonas stutzeri with substantially improved 
catalytic efficiency towards NADP+ and higher operational stability than the wild type 
enzyme. This regeneration approach is less established than those employing for example, 
formate dehydrogenase or glucose dehydrogenase. However, it might become a true 
alternative for certain applications with its attractive features of high catalytic efficiency 
(kcat/KM,NADPH), high productivity, a low KM value for the second substrate phosphite and good 
operational stability.[7] Additionally a catalase was included to decompose H2O2, produced by 
partial uncoupling in P450 BM3.[6] 
In the metathesis reaction between 10-undecenoic acid and trans-3-hexene, two 
products and their respective double bond isomers can be formed (other than the starting 
materials and not counting ethylene, Scheme^^2). Among all alkene-containing species 
present in the mixture, the monooxygenase recognizes preferentially 10-tridecenoic acid 
which is converted to the corresponding epoxides with moderate enantioselectivity (38^% ee 
for the E-epoxide). The continual removal of 10-tridecenoic acid from the equilibrating alkene 
mixture by the monooxygenase leads to a higher concentration of the final product (a 
stereoisomeric mixture of 10,11-epoxytridecanoic acid) than would be possible in an 
analogous sequential transformation. 
Varying the loading of 10-undecenoic acid and/or its ratio to trans-3-hexene, at 
constant P450 BM3 concentration but with the Ru-catalyst adjusted to 2.5^^mol^% (relative 
to 10-undecenoic acid), can lead to a substantial yield increase of up to 2.6 fold compared to 
the hypothetical sequential process. With 12.5^^mM initial loading of 10-undecenoic acid in 
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the organic phase and only 1.5 equivalents of 3-hexene, a GC-MS yield of 70^% 10,11-
epoxytridecanoic acid was obtained. 
Hartwig, Zhao and coworkers have thereby demonstrated that the simultaneous 
application of a homogeneous olefin metathesis catalyst with a biocatalyst can be 
advantageous.[8] Key to this achievement may be the compartmentalization of the 
homogeneous- and enzymatic catalysts in two immiscible phases. Indeed, it has been 
demonstrated that both catalyst classes (homogeneous catalysts and biocatalysts) can suffer 
from mutual inhibition. Several strategies have been successfully implemented to overcome 
this challenge. These include encapsulation of the organometallic catalyst within a 
supramolecular capsule or a host protein, phase separation of the partners by immobilisation 
on a solid support or running the reaction under biphasic conditions. These designs ensure that 
the organometallic moiety is physically separated from the enzyme thus preventing 
deactivation of one or both catalytic partners.[1] 
The optimization of a concurrent catalytic system with two or more catalysts working 
in concert requires in general more effort due to additional restraints. For example the 
temperature maximum is dictated by the thermally least stable catalytic partner. Accordingly, 
it is likely that aspects of the individual steps might proceed more efficiently when they are 
conducted in a sequential manner. A sequential process for the current example however, 
would be limited in terms of yield by the equilibrium distribution of alkenes for a given set of 
reaction conditions. 
The present system employs a substantial loading of the metathesis catalyst, which, 
although not at all unusual in laboratory scale metathesis reactions, may limit its large scale 
application due to the high cost of the ruthenium based catalyst. The development of 
metathesis catalysts and the engineering of reaction conditions which enable high turnover 
numbers in combined action with biocatalysts are accordingly of high importance.[9] 
The authors extended the application of the concept in the tandem olefin cross-
metathesis/epoxidation of 4-butenyloxybenzoic acid with trans-3-hexene at a yield increase of 
1.3 fold compared to the hypothetical sequential process. Other applications may be imagined 
such as the selective processing of one double bond isomer from an equilibrating mixture of 
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intermediates if the respective enzymatic partner for the desired subsequent transformation 
can be identified. Enzymatic partners are in the first instance limited to biocatalysts which 
transform double bonds (directly or indirectly) so that the products are not subject to alkene 
metathesis. Apart from the required specificity for the choice intermediate, compatibility with 
the metathesis conditions needs to be given or achieved. The technologies to tailor 
biocatalysts to specific needs also brighten the Future for potential simultaneous chemo-
enzymatic cascades.[10] 
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Scheme^^1 A successful concept in concurrent chemo-enzymatic catalysis combines a 
reversible transition metal catalyzed reaction with an irreversible and highly specific 
enzymatic transformation. 
 
 
 
 
 
 
 
 
Scheme^^2 Biphasic reaction Scheme for the cooperative conversion of 10-undecenoic 
acid and trans-3-hexene by a Ru-based metathesis catalyst and P450 BM3. Phosphite 
dehydrogenase (PTDH) is employed for NADPH regeneration. Catalase prevents the 
accumulation of H2O2 caused by uncoupling in the P450 BM3 monooxygenase. E/Z=6:1 for 
the epoxide product. Adapted from reference^^3 with permission from Wiley. 
 
 
 
 
 
